Nu Skin Enterprises (NYSE:NUS) Announces Quarterly Earnings Results, Meets Estimates

Nu Skin Enterprises (NYSE:NUSGet Free Report) issued its quarterly earnings data on Monday. The company reported $0.20 EPS for the quarter, meeting the consensus estimate of $0.20, FiscalAI reports. The company had revenue of $320.11 million during the quarter, compared to analysts’ expectations of $345.20 million. Nu Skin Enterprises had a net margin of 3.78% and a return on equity of 7.47%. Nu Skin Enterprises updated its FY 2026 guidance to 0.700-0.900 EPS and its Q3 2026 guidance to 0.100-0.200 EPS.

Here are the key takeaways from Nu Skin Enterprises’ conference call:

  • Second-quarter revenue was $320.1 million, including a $4 million foreign-currency headwind, while adjusted EPS was near the midpoint of guidance. Adjusted operating margin declined to 6.1% from 8.0% year over year.
  • Prysm iO adoption continued to build, with more than 39,000 devices placed—up nearly 30% quarter over quarter—and 2.5 million scans. Nu Skin expects 50,000–60,000 placements by year-end and plans to launch an AI-enabled app to improve personalization, conversion, and customer engagement.
  • Nu Skin delayed the formal India market launch to the first half of 2027 while it refines local manufacturing, logistics, technology integration, and the affiliate business model.
  • Management said recruiting and leadership development remain below the levels needed for sustainable growth, while affiliates are still adapting to selling the wellness-focused Prysm iO product rather than the company’s historically stronger beauty offerings.
  • Full-year guidance now calls for revenue of $1.28 billion–$1.35 billion and adjusted EPS of $0.70–$0.90. Reported results included a $78.9 million goodwill impairment and a $167.5 million deferred-tax valuation allowance, while the planned East-West restructuring is expected to incur $5 million–$10 million in cash transition costs.

Nu Skin Enterprises Price Performance

NYSE:NUS traded down $0.33 during midday trading on Monday, hitting $5.16. The company had a trading volume of 1,116,925 shares, compared to its average volume of 596,442. Nu Skin Enterprises has a 52-week low of $4.89 and a 52-week high of $14.62. The stock’s fifty day moving average price is $5.22 and its 200-day moving average price is $6.98. The company has a market capitalization of $250.52 million, a PE ratio of 4.69 and a beta of 0.98. The company has a quick ratio of 1.34, a current ratio of 2.03 and a debt-to-equity ratio of 0.26.

Institutional Investors Weigh In On Nu Skin Enterprises

Several hedge funds have recently added to or reduced their stakes in NUS. Wexford Capital LP bought a new position in shares of Nu Skin Enterprises during the 3rd quarter valued at about $40,000. Banque Cantonale Vaudoise bought a new position in Nu Skin Enterprises during the third quarter valued at approximately $57,000. Tower Research Capital LLC TRC raised its stake in shares of Nu Skin Enterprises by 107.4% during the second quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock worth $40,000 after acquiring an additional 2,614 shares in the last quarter. Quadrant Capital Group LLC purchased a new stake in shares of Nu Skin Enterprises in the 3rd quarter valued at $85,000. Finally, National Bank of Canada FI grew its holdings in shares of Nu Skin Enterprises by 1,040,200.0% during the 3rd quarter. National Bank of Canada FI now owns 10,403 shares of the company’s stock valued at $127,000 after purchasing an additional 10,402 shares during the last quarter. Institutional investors own 82.84% of the company’s stock.

Trending Headlines about Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

  • Positive Sentiment: Nu Skin reported adjusted second-quarter EPS of $0.20, in line with consensus estimates, although this was down from $0.43 a year earlier. Nu Skin Enterprises Matches Q2 Earnings Estimates
  • Positive Sentiment: The board declared a quarterly cash dividend of $0.06 per share, payable September 9 to shareholders of record on August 28, supporting the stock’s income appeal. Nu Skin Announces Quarterly Dividend
  • Neutral Sentiment: Institutional positioning was mixed: 76 investors added shares in the latest quarter, while 93 reduced their holdings. Recent insider activity also consisted of two reported sales and no purchases, a cautionary signal but not necessarily a major driver by itself.
  • Negative Sentiment: Second-quarter revenue fell 17.1% year over year to $320.1 million, below analyst expectations of roughly $345 million-$349 million. Customers declined 14% to 660,037, while paid affiliates fell 8% and sales leaders decreased 9%, indicating continued weakness in the company’s sales network. Nu Skin Reports Second Quarter Results
  • Negative Sentiment: GAAP results included a $249.8 million net loss, or $5.14 per diluted share, compared with adjusted EPS of $0.20. The loss reflected non-cash impairment and tax charges, but still increases concern about business conditions and asset values.
  • Negative Sentiment: Nu Skin lowered its outlook below consensus. Full-year 2026 EPS guidance of $0.70-$0.90 trails the $1.00 estimate, while third-quarter EPS guidance of $0.10-$0.20 is well below the $0.32 consensus. Third-quarter revenue guidance of $310 million-$340 million also falls short of the $375.5 million estimate, reinforcing expectations for continued sales pressure.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on NUS shares. Zacks Research upgraded shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Weiss Ratings downgraded Nu Skin Enterprises from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, June 4th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Reduce”.

View Our Latest Report on Nu Skin Enterprises

About Nu Skin Enterprises

(Get Free Report)

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.

Featured Stories

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.